Correlation between the number of removed lymph nodes and ratio of lymph node metastasis in stage IB-IIA cervical cancer

AMAÇ: Bu çalışmada çıkartılan lenf nodu sayısıyla lenf nodu pozitifliği arasındaki ilişki arsındaki ilişki araştırıldı. GEREÇ VE YÖNTEM: 1993-2007 arasında tanısı konup tip III radikal histerektomi ve sistematik pelvik ve para-aortik lenfa denektomi yapılan 250 hastanın verileri incelendi. Hastaların 171’i IB1, 30’u IB2 ve 49’u IIA’ydı. BULGULAR: Hastaların yaş ortalaması 53.9’du. Hastaların %34’ünde lenf nodu pozitifliği saptandı. Çıkarılan lenf nodu sa yısı median 52’ydi (13-160). Hastaların 9’unda 20 ve altında lenf nodu çıkartılmışken, 29’unda 21-30 arasında, 46’sında 31- 40 arasında, 36’sında 41-50 arasında, 39’unda 51-60 arasın da, 39’unda 61-70 arasında, 25’inde 71-80 arasında ve 27’sin de 80’in üzerinde lenf nodunun çıkartıldığı belirlendi. En düşük lenf nodu pozitifliği lenf nodunun en az çıkarıldığı grupta (%11.1), en yüksek lenf nodu pozitifliği (%60.4) 31-40 arasın da lenf nodu çıkarılan grupta gözlendi. Ancak, çıkarılan lenf no du sayısıyla metastatik lenf nodunu saptayabilme arasında iliş ki bulunmadı. SONUÇ: Çıkarılan lenf nodu sayısıyla lenf nodu metastazını saptayabilme arasında ilişki olmadığı görüldü. Ancak, en düşük lenf nodu pozitifliği en az lenf nodu çıkarılan gruptaydı.

Evre IB-IIA aerviks kanserinde çıkarılan lenf nodu sayısı ve lenf nodu metastaz oranı arasındaki korelasyon

Objective: Understanding the relation between the numbers of removed lymph node and getting positive lymph node. Study Design: Medical records of 250 patients diagnosed as stage IB-IIA cervical cancer and treated with type III radical hysterectomy plus systematic pelvic and para-aortic lymphadenectomy in between January 1993 and December 2007 were evaluated. Clinical stage IB1 tumor was present in 171 patients, IB2 in 30 patients and IIA in 49 patients. Results: The mean age of patients was 53.9 years. The metastatic node was determined in 34% of patients. The median number of removed nodes was 52 (13-160). It was removed 20 or less lymph nodes in 3.6% of patients, 21-30 lymph nodes removed in 11.6% of patients, 31-40 lymph nodes in 18.4% of patients, 41-50 lymph nodes in 14.4% of patients, 51- 60 lymph nodes in 15.6% of patients, 61-70 lymph nodes in 15.6% of patients, 71- 80 lymph nodes in 10% of patients and more than 80 in 10.8% of patients. The positive lymph node incidence was at minimum (11.1 %) in the ≤20 lymph nodes removed group and incidence was at maximum (60.4%) was observed in 31-40 lymph nodes removed group. However, there was no significant relationship between the number of removed nodes and getting positive lymph nodes. Conclusion: There was no relationship between number of lymph nodes removed and the chance of finding metastasis. However, the percentage of positive lymph nodes was lowest in the group where lowest number of nodes was removed.

Kaynakça

1. Sakuragi N, Satoh C, Takeda N, et al. Incidence and dis tribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervi cal carcinoma treated with radical hysterectomy. Cancer 1999; 85(7):1547-54

2. Benedetti-Panici P, Maneschi F, Scambia G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 1996; 62(1):19-24

3. Benedetti-Panici P, Maneschi F, D'Andrea G, et al. Early cervical carcinoma: the natural history of lymph node in volvement redefined on the basis of thorough parametrec tomy and giant section study. Cancer 2000; 88(10):2267- 74

4. Benedetti-Panici P, Maggioni A, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus re section of bulky nodes only in optimally debulked ad vanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 2005;97(8):560-6

5. Hacker NF, Wain GV, Nicklin JL. Resection of bulky pos itive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995; 5(4):250-6.

6. Cosin JA, Fowler JM, Chen MD, Paley PJ, Carson LF, Twiggs LB. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 1998; 82(11):2241-8.

7. Sevin BU, Nadji M, Lampe B, et al. Prognostic factors of early stage cervical cancer treated by radical hysterec tomy. Cancer 1995; 76:1978-86

8. Piura B, Rabinovich A, Friger M. Surgical pathologic fac tors in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissec tion: association with administration of adjuvant radio therapy and effect on survival. Eur J Gynaecol Oncol. 2006; 27(6):573-8.

9. Tanaka Y, Sawada S, Murata T. Relationship between lymph node metastases and prognosis in patients irradi ated postoperatively for carcinoma of the uterine cervix. Acta Radiol Oncol. 1984; 23(6):455-9.

10. Tinga DJ, Timmer PR, Bouma J, Aalders JG. Prognostic significance of single versus multiple lymph node metas tases in cervical carcinoma stage IB. Gynecol Oncol. 1990 Nov; 39(2):175-80.

11. Novaković P, Mandić A, Vujkov T, et al. Radical hys terectomy for stage IB1 cervical carcinoma: lymph node metastasis as a prognostic factor. J BUON 2002;7(3):247- 50

12. Pieterse QD, Kenter GG, Gaarenstroom KN et al. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cer vical cancer. EJSO 2007, 33:216-21

13. Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney DK. Prognostic Significance of Histology and Positive Lymph Node Involvement Following Radical Hysterectomy in Carcinoma of the Cervix American Journal of Clinical Oncology Volume 32, Number 4, August 2009

14. Stehman FB, Ali S, DiSaia PJ. Node count and groin re currence in early vulvar cancer: A Gynecologic Oncology Group study. Gynecol Oncol. 2009 Apr; 113(1):52-6.

15. Lutman CV, Havrilesky LJ, Cragun JM et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk his tology. Gynecol Oncol. 2006 Jul; 102(1):92-7.

16. Altorki NK, Zhou XK, Stiles B et al. Total number of re sected lymph nodes predicts survival in esophageal can cer. Ann Surg. 2008 Aug; 248(2):221-6.

17. Peyre CG, Hagen JA, DeMeester SR et al. The number of lymph nodes removed predicts survival in esophageal can cer: an international study on the impact of extent of sur gical resection. Ann Surg. 2008 Oct; 248(4):549-56.

18. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-nega tive esophageal cancer. Cancer. 2008 Mar 15;112(6): 1239-46.

19. Terada KY, Morley GW, Roberts JA. Stage IB carcinoma of the cervix with lymph node metastases. Gynecol Oncol. 1988;3 1:389-395.

20. Sakuragi N, Satoh C, Tanaka T, et al. The incidence and clinical significance of paraaortic lymph node metastases in patients with uterine cervical cancer. Nippon Sanka Fujinka Gakkai Zasshi. 1990; 42:60-66 (abs).

21. Berman ML, Keys H, Creasman W, et al. Survival and patterns of recurrence in cervical cancer metastatic to pe riaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 1984;19:8-16.

22. Hu Y, Hu C, Zhang H, Ping Y, Chen LQ. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma? Ann Surg Oncol. 2010 Mar; 17(3):784-90.

Kaynak Göster

  • ISSN: 1300-4751
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 1995

7.5b 3b

Sayıdaki Diğer Makaleler

Maternal and fetal outcomes among pregnant women with immune thrombocytopenic purpura

A. İrfan GÜZEL, Umur KUYUMCUOĞLU, Mahmut ERDEMOĞLU

Uterus unicornis and unilateral ovarian and renal agenesis in a case with primary amenorrhoea

Mehmet A. OSMANAĞAOĞLU, Süleyman GÜVEN, Turhan ARAN, MUSTAFA ÖZGÜR, Barış VURALLI, Görkem Ceylan İLHAN, Hasan BOZKAYA

Cord blood leptin levels in gestational diabetes

Özlem ŞENGÜL, Tamer MUNGAN, EVRİM ERDEMOĞLU, Göksel İSLAMOĞLU, Füsun CANTÜRK

Comparison of the “Twenty-four hour pH Monitoring Test” results of the pregnant and non-pregnant reflux patients

Mehmet VURAL, Ülkü BAYAR, Yücel ÜSTÜNDAĞ, Selim AYDEMİR, Mustafa BAŞARAN

Assessment of changes in uterine and subendometrial blood flows by doopler sonography in women undergoing assisted reproduction

Ayşe Figen TÜRKÇAPAR, Özlem MORALOĞLU, Tülin ÖZDENER, Berna SEÇKİN, Esra TONGUÇ, Turgut VAR, Mustafa UĞUR

Laparoscopic conservative approach to noncommunating rudimentary uıterin horn pregnancy

Esra Ayşin TONGUÇ, Turgut VAR, Özlem MORALOĞLU, Erkan AKAN, Sertaç BATIOĞLU

Does cancer therapy causes cancer? A case report and mini review of the literature

Nikolaos THOMAKOS, Alexandros RODOLAKIS, Nikolaos AKRIVOS, Pantelis PALAIOLOGOS, Dimitrios HAIDOPOULOS, Georgios VLAHOS, Aris ANTSAKLIS

Retrospective analysis of placental invasion anomalies in a university hospital

Devran BILDIRCIN, Miğraci TOSUN, Erdal MALATYALIOĞLU, Eren Ensari YAZICI, Mehmet KEFELİ, Mehmet ÇETİNKAYA, MEHMET SAKINCI, Handan ÇELİK

The association of bacterial vaginosis with gynecologic complaints and clinical data

Gözde IŞIK, Ayşegül KÜÇÜK, Sayeste DEMİREZEN, Mehmet Sinan BEKSAÇ, Gülşen HASÇELİK

The comparison of depression, anxiety and quality of life levels among trimesters of pregnancy

Savaş KARATAYLI, Kazım GEZGİNÇ, Faruk UĞUZ, Rengin KARATAYLI, ALİ SAVAŞ ÇİLLİ